Mostrar el registro sencillo del ítem
dc.contributor.author
Abu Raya, Bahaa
dc.contributor.author
Forsyth, Kevin
dc.contributor.author
Halperin, Scott A.
dc.contributor.author
Maertens, Kirsten
dc.contributor.author
Jones, Christine E.
dc.contributor.author
Heininger, Ulrich
dc.contributor.author
Hozbor, Daniela Flavia
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Heinz Wirsing von König, Carl
dc.contributor.author
Chitkara, Amar J.
dc.contributor.author
Muloiwa, Rudzani
dc.contributor.author
Tan, Tina Q.
dc.date.available
2023-10-06T14:47:22Z
dc.date.issued
2022-12
dc.identifier.citation
Abu Raya, Bahaa; Forsyth, Kevin; Halperin, Scott A.; Maertens, Kirsten; Jones, Christine E.; et al.; Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative; MDPI; Vaccines; 10; 12; 12-2022; 1-16
dc.identifier.issn
2076-393X
dc.identifier.uri
http://hdl.handle.net/11336/214363
dc.description.abstract
Vaccination against pertussis in pregnancy is safe for pregnant women and newborns. Vaccination against pertussis during the second or early third trimester of pregnancy is highly protective against pertussis in young infants. Vaccination early in the third trimester versus vaccination late in the third trimester is associated with higher newborn anti-B. pertussis antibody levels. Infants whose mothers were vaccinated in pregnancy have less boosting of anti-B. pertussis antibody concentrations after their own vaccination, but this is not clinically significant. More immunogenicity and vaccine effectiveness studies are needed in countries using whole-cell pertussis vaccines. Vaccination in pregnancy induces anti-B. pertussis antibodies in breast milk. COVID-19 mitigation strategies have resulted in a significant decrease in B. pertussis circulation, which could negatively affect population immunity against B. pertussis. Highlights: Infants are at high risk for severe morbidity and mortality from pertussis disease during early infancy. Vaccination against pertussis in pregnancy has emerged as the ideal strategy to protect infants during these early, vulnerable, first months of life. On 30 November and 1 December 2021, the Global Pertussis Initiative held a meeting that aimed to discuss and review the most up-to-date scientific literature supporting vaccination against pertussis in pregnancy and outstanding scientific questions. Herein, we review the current and historically published literature and summarize the findings as consensus statements on vaccination against pertussis in pregnancy on behalf of the Global Pertussis Initiative.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
MDPI
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/
dc.subject
GLOBAL PERTUSSIS INITIATIVE
dc.subject
IMMUNITY
dc.subject
PERTUSSIS
dc.subject
PREGNANCY
dc.subject
PROTECTION
dc.subject
VACCINATION
dc.subject.classification
Otras Ciencias Biológicas
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Ciencias Biológicas
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-07-04T10:59:08Z
dc.journal.volume
10
dc.journal.number
12
dc.journal.pagination
1-16
dc.journal.pais
Países Bajos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Abu Raya, Bahaa. University of British Columbia; Canadá
dc.description.fil
Fil: Forsyth, Kevin. Flinders University.; Australia
dc.description.fil
Fil: Halperin, Scott A.. Dalhousie University Halifax; Canadá
dc.description.fil
Fil: Maertens, Kirsten. Universiteit Antwerp; Bélgica
dc.description.fil
Fil: Jones, Christine E.. University of Southampton; Reino Unido
dc.description.fil
Fil: Heininger, Ulrich. University of Basel Children’s Hospital; Suiza
dc.description.fil
Fil: Hozbor, Daniela Flavia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular; Argentina
dc.description.fil
Fil: Heinz Wirsing von König, Carl. No especifíca;
dc.description.fil
Fil: Chitkara, Amar J.. Max Super Speciality Hospital; India
dc.description.fil
Fil: Muloiwa, Rudzani. University of Cape Town; Sudáfrica
dc.description.fil
Fil: Tan, Tina Q.. Northwestern University; Estados Unidos
dc.journal.title
Vaccines
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3390/vaccines10121990
Archivos asociados